
This study assessed the effectiveness and safety of rapidly increasing guideline-directed medical therapies (GDMT) in men and women hospitalized for acute heart failure (AHF). The study found that a higher proportion of both men and women in the high-intensity care group achieved full doses of GDMT compared to the usual care group by day 90. There were no significant differences between men and women in the primary endpoint of heart failure readmission or death at 180 days. These findings suggest that rapid up-titration of GDMT after AHF hospitalization can be implemented similarly for both men and women, resulting in reduced risk of death or heart failure readmission and improved quality of life with a similar safety profile.
Like
Save
Share